News
Jan. 5, 2007 — An announcement from AstraZeneca is expected soon about the company’s experimental heart drug AGI-1067, the company’s partner AtheroGenics Inc. hopes to present results from a pivotal Phase III clinical trial to the American College of Cardiology (ACC) meeting in New Orleans.
January 04, 2007
News
Jan. 5, 2007 — A report in the January issue of the Journal of the American College of Cardiology finds that as many as ...
January 04, 2007News
Jan. 5, 2007 — MedicalCV, Inc., a cardiovascular surgery company, says it will amend its 510(k) submission for clearance ...
January 04, 2007Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024News
Jan. 5, 2007 — A French court has ruled that Abbott Laboratories’ Xience V drug-eluting coronary stents infringe patents ...
January 04, 2007News
AP reports that a Dec. 27 Medicare proposal may could double the number of hospitals authorized to implant the HeartMate ...
January 03, 2007News
HMS Technologies, Inc. (HMS), the exclusive federal distributor for the commercial versions of the EZ-IO Emergency ...
January 03, 2007Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024News
Non-white, low-income patients without commercial insurance are more likely to delay diagnosis of peripheral vascular ...
January 03, 2007News
Dual-chamber pacing coupled with Boston Scientific's AV Search Hysteresis (AVSH) programming has the potential to reduce ...
January 02, 2007News
A review by physicians at Tulane University School of Public Health and Tropical Medicine shows that Vitamin B12 ...
January 02, 2007Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023News
Heartwire cites results of a new study finding that current heart-failure performance measures, with the exception of ...
January 02, 2007News
Implant Sciences Corp. a wholly-owned German subsidiary of CorNova, Inc., has received CE Mark marketing approval for ...
January 01, 2007News
Swiss researchers may have discovered the reason drug-eluting stents cause thrombosis, and their study results are ...
January 01, 2007Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023News
Reuters reports that a study of military veterans suffering from post-traumatic stress disorder showed that more severe their anxiety, the greater their risk of heart disease. Adding to the long-recognized connection between stress and heart disease, researchers at the Harvard School of Public Health in Boston said that relationship existed among nearly 2,000 Boston-area veterans.
January 01, 2007News
A new intravascular MRI catheter developed by Topspin Medical has received CE Mark approval, and the Israeli company ...
January 01, 2007News
The latest in thrombus removal devices from Possis has received FDA clearance — the new AngioJet Ultra Thrombectomy System is the next-generation, re-engineered version of the company’s AngioJet Rheolytic Thrombectomy System.
December 20, 2006© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now